Overview
Hereditary mixed polyposis syndrome (HMPS) is a rare inherited condition characterized by the development of multiple types of polyps in the colon and rectum. Unlike other polyposis syndromes where a single polyp type predominates, individuals with HMPS develop a mixture of polyp types including hyperplastic polyps, atypical juvenile polyps, sessile serrated adenomas, and conventional adenomas (tubular, tubulovillous, or villous adenomas). This mixed histological presentation is a hallmark feature that distinguishes HMPS from other hereditary polyposis conditions such as familial adenomatous polyposis or juvenile polyposis syndrome. The condition primarily affects the gastrointestinal system, specifically the large bowel. Polyps typically develop during adulthood and can number from a few to several dozen. A major concern with HMPS is the significantly increased risk of colorectal cancer if the condition is left unmonitored or untreated. The syndrome has been linked to genetic alterations in the region of chromosome 10q23 and, in some families, to duplications involving the GREM1 gene (also known as the SCG2 locus on chromosome 15q13.3), which encodes a BMP antagonist. Duplication upstream of GREM1 leads to ectopic expression of this gene in colonic epithelium, disrupting normal BMP signaling and promoting polyp formation. There is currently no cure for HMPS, and management focuses on regular colonoscopic surveillance to detect and remove polyps before they progress to malignancy. The frequency and timing of surveillance colonoscopies are individualized based on polyp burden and family history. In cases where polyps are too numerous to manage endoscopically, or if cancer develops, surgical intervention such as colectomy may be necessary. Genetic counseling is recommended for affected individuals and their at-risk family members to facilitate early detection and appropriate screening strategies.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
2 eventsSecond Affiliated Hospital, School of Medicine, Zhejiang University — PHASE2
Tugba Aydin
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Hereditary mixed polyposis syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary mixed polyposis syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary mixed polyposis syndrome.
Community
No community posts yet. Be the first to share your experience with Hereditary mixed polyposis syndrome.
Start the conversation →Latest news about Hereditary mixed polyposis syndrome
No recent news articles for Hereditary mixed polyposis syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary mixed polyposis syndrome
What is Hereditary mixed polyposis syndrome?
Hereditary mixed polyposis syndrome (HMPS) is a rare inherited condition characterized by the development of multiple types of polyps in the colon and rectum. Unlike other polyposis syndromes where a single polyp type predominates, individuals with HMPS develop a mixture of polyp types including hyperplastic polyps, atypical juvenile polyps, sessile serrated adenomas, and conventional adenomas (tubular, tubulovillous, or villous adenomas). This mixed histological presentation is a hallmark feature that distinguishes HMPS from other hereditary polyposis conditions such as familial adenomatous p
How is Hereditary mixed polyposis syndrome inherited?
Hereditary mixed polyposis syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hereditary mixed polyposis syndrome typically begin?
Typical onset of Hereditary mixed polyposis syndrome is adult. Age of onset can vary across affected individuals.
Which specialists treat Hereditary mixed polyposis syndrome?
2 specialists and care centers treating Hereditary mixed polyposis syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.